Results 141 to 150 of about 7,229 (203)

Eligibility and factors associated with long-acting injectable cabotegravir-rilpivirine initiation in an urban academic HIV clinic. [PDF]

J Antimicrob Chemother
Liegeon G, Friedman E, Kaperak C, Djuricich P, Dawdani A, Plotkin S, Schmitt J, Hazra A, Christopoulos KA, Schneider JA, McNulty MC.   +10 more
europepmc   +1 more source

New drugs: Rilpivirine

Australian Prescriber, 2012
openaire   +1 more source

The Epidemiology of HIV-1 Resistance to Two-Drug Regimens in Multicenter Cohort From Poland-A Cross-Sectional Study. [PDF]

Health Sci Rep
Załęski A, Lembas A, Osińska J, Dyda T, Suchacz M, Stempkowska-Rejek J, Orzechowska J, Wiercińska-Drapało A.   +7 more
europepmc   +1 more source